Therefore, results of our present study first reveal that the interaction between carcinoma and immune cells could alter the expression of immune checkpoint‐related molecules in both carcinoma and immune cells, such as PD‐L1, PD‐1, and B7‐1. The gene discussed is CD80; the disease is carcinoma.